Emily K Bergsland, MD

2 locations · University of California San Francisco · UCSF Medical Group Business Services

Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.

12 plans · 2 carriers

Licence G70524 · Current

Licensed to practise in California · since 1990 · expires 2026-12-31 · University of Minnesota Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

• American Board of Internal Medicine - Medical Oncology

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

• UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
  Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024

$130,470

Medicare paid this office $130,470 for 156 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Who their Medicare patients are

156 Original Medicare patients in 2024. Average age 72 · Under 65 10% · 85 and older 7% · Women 47% · Also on Medicaid 12% · Health risk score 2.97. Sicker patients than 9 in 10 peers; the typical medical oncology clinician is at 2.11.

Conditions among them: High blood pressure 64% · Diabetes 35% · Chronic kidney disease 22% · Cancer 22% · Coronary heart disease 19% · Atrial fibrillation 13% · Depression 11% · Heart failure 10% · COPD 8%.

The office billed $1,157,081, Medicare allowed $165,215 and paid $130,470; for 2,077 services of 12 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

$1,116 in 2023

Medicaid paid $1,116 for 12 billed services this clinician did in 2023, up to 12 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their 14 Part D prescriptions in 2023. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

Year by year

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

$96 in 2025

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Medicare did not publish checkup rates for this clinician.

NPI

1295792729

Licence

CA G70524California G70524: Current · expires 2026-12-31

Group

University of California San Francisco · UCSF Medical Group Business Services

Video visits

Lists video visits

Gender

Female